Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202203545530206Phase 3Completed
Phase 3, randomised, double-blind trial in postoperative pain comparing Bupivacaine only, Fentanyl group and Ketamine group (3 arms). Primary endpoint: Cumulative analgesic consumption in the first 24 postoperative hours. Started Apr 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202203545530206.